In two systemic meta-analyses, GLUT1 expression in gallbladder cancer, pancreatic cancer, breast cancer, oral cancer, and lung cancer did correspond to higher tumor grade, lymph node metastasis and larger tumor size, which are all linked to poorer overall survival [29]. The gene discussed is SLC2A1; the disease is breast carcinoma.